Naoya Yoshida, Kojiro Eto, Takashi Matsumoto, Keisuke Kosumi, Yu Imamura, Masaaki Iwatsuki, Yoshifumi Baba, Yuji Miyamoto, Masayuki Watanabe, Hideo Baba. Omental Flap Wrapping around the Esophagogastric Anastomosis and Association with Anastomotic Leak in Esophagectomy for Esophageal Cancer: A Propensity Score-Matching Analysis. Journal of the American College of Surgeons. 2022. 236. 1. 189-197
Suguru Maruyama, Akihiko Okamura, Yasukazu Kanie, Kei Sakamoto, Daisuke Fujiwara, Jun Kanamori, Yu Imamura, Koshi Kumagai, Masayuki Watanabe. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbeck's archives of surgery. 2022. 407. 5. 1901-1909
Naoya Yoshida, Tomo Horinouchi, Kojiro Eto, Kazuto Harada, Hiroshi Sawayama, Yu Imamura, Masaaki Iwatsuki, Takatsugu Ishimoto, Yoshifumi Baba, Yuji Miyamoto, et al. Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy: A Retrospective Study. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. 2022. 3. 2. e153
Yu Imamura, Keisho Chin, Takahiro Tsushima, Yasuhiro Tsubosa, Hiroki Hara, Takashi Fukuda, Motoo Nomura, Shigeru Tsunoda, Takashi Ogata, Tsutomu Hayashi, et al. Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
Yu Imamura, Tasuku Toihata, Manabu Takamatsu, Norio Tanaka, Shinji Mine, Seiichi Mori, Eiji Oki, Masaru Morita, Hideo Baba, Takeshi Sano, et al. MSI-low is an intermediate type between MSI-high and MSS in esophagogastric junction adenocarcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2019. 37. 4
Yu Imamura, Shinji Mine, Naoki Hiki, Eiji Oki, Manabu Yamamoto, Masaru Morita, Yoshihiko Maehara, Hideo Baba, Takeshi Sano, Masayuki Watanabe. Molecular Status Changes According to Tumor Location in EGJ Adenocarcinoma Abstracts. DIGESTION. 2019. 99. 1. 100-101
Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial.
(Gastrointestinal Cancers Symposium (ASCO-GI 2021) 2021)
Examining #16 and #101/106rec nodes as regional lymph nodes to be dissected for EGJ adenocarcinoma.
(第75回日本消化器外科学会総会 2020)
2010/12 - 2013/04 Dana-Farber Cancer Institute/Harvard Cancer Center Department of Medical Oncology Research Fellow
2010/04 - 2010/11 熊本大学医学部附属病院 消化器外科 医員
全件表示
委員歴 (3件):
2021/07 - 現在 日本食道学会 評議員
2020/05 - 現在 日本消化器外科学会 評議員
2013 - 現在 日本胃癌学会 代議員
受賞 (7件):
2022 - 第15回臨床薬理研究振興財団研究大賞
2022 - 日本消化管学会 最優秀サイテーション賞
2021 - 日本消化器癌発生学会 優秀演題賞
2018 - The International Gastrointestinal Consensus Symposium, Young Investigator Award
2017 - 第89回日本胃癌学会総会 優秀研究賞
2016 - 第88回日本胃癌学会総会 優秀ポスター賞
2014 - 日本消化器外科学会 Young Investigator of the Year 2014
全件表示
所属学会 (12件):
American College of Surgeons
, American Society of Clinical Oncology
, 日本癌学会
, 日本消化器病学会
, 日本胸部外科学会
, 日本食道学会
, 日本胃癌学会
, 日本内視鏡外科学会
, 日本癌治療学会
, 日本消化器外科学会
, 日本外科学会
, 日本気管食道学会